Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mulligan

Showing results (181-190 of 245) with videos related to

Pageof 25
Sort By:
The Orthopedic Clinics of North America|November 20, 2019
Safety and Cost-Effectiveness of Outpatient Unicompartmental Knee Arthroplasty in the Ambulatory Surgery Center: A Matched Cohort StudyMarcus C Ford, Jordan D Walters, Ryan P Mulligan, et al.
Journal of Biomedical Optics|July 17, 2024
Capturing cell morphology dynamics with high temporal resolution using single-shot quantitative phase gradient imagingSun Woong Hur, Minsung Kwon, Revathi Manoharaan, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 10, 2021
Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell linesJuhura G Almazi, Munther Alomari, Larissa Belov, et al.
Leukemia & Lymphoma|June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaJane A Freeman, Kyle R Crassini, O Giles Best, et al.
Plos One|August 2, 2011
Analysis of imprinted gene expression in normal fertilized and uniparental preimplantation porcine embryosChi-Hun Park, Kyung-Jun Uh, Brendan P Mulligan, et al.
Leukemia & Lymphoma|October 1, 2015
Protein profiles distinguish stable and progressive chronic lymphocytic leukemiaPauline Y Huang, Swetlana Mactier, Natalie Armacki, et al.
Ejhaem|July 18, 2022
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.
Leukemia & Lymphoma|July 27, 2025
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in AustraliaStephen P Mulligan, Philip A Thompson, Joel Wight, et al.
Journal of Proteome Research|March 6, 2013
Hsp90 Inhibitor SNX-7081 dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cellsYiping Che, O Giles Best, Ling Zhong, et al.
British Journal of Haematology|July 1, 1995
The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionI Cunningham, S J MacCallum, M D Nicholls, et al.
Pageof 25

Showing results (181-190 of 245) with videos related to

Sort By:
Pageof 25
The Orthopedic Clinics of North America|November 20, 2019
Safety and Cost-Effectiveness of Outpatient Unicompartmental Knee Arthroplasty in the Ambulatory Surgery Center: A Matched Cohort StudyMarcus C Ford, Jordan D Walters, Ryan P Mulligan, et al.
Journal of Biomedical Optics|July 17, 2024
Capturing cell morphology dynamics with high temporal resolution using single-shot quantitative phase gradient imagingSun Woong Hur, Minsung Kwon, Revathi Manoharaan, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 10, 2021
Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell linesJuhura G Almazi, Munther Alomari, Larissa Belov, et al.
Leukemia & Lymphoma|June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaJane A Freeman, Kyle R Crassini, O Giles Best, et al.
Plos One|August 2, 2011
Analysis of imprinted gene expression in normal fertilized and uniparental preimplantation porcine embryosChi-Hun Park, Kyung-Jun Uh, Brendan P Mulligan, et al.
Leukemia & Lymphoma|October 1, 2015
Protein profiles distinguish stable and progressive chronic lymphocytic leukemiaPauline Y Huang, Swetlana Mactier, Natalie Armacki, et al.
Ejhaem|July 18, 2022
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLLNarjis Fatima, Yandong Shen, Kyle Crassini, et al.
Leukemia & Lymphoma|July 27, 2025
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in AustraliaStephen P Mulligan, Philip A Thompson, Joel Wight, et al.
Journal of Proteome Research|March 6, 2013
Hsp90 Inhibitor SNX-7081 dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cellsYiping Che, O Giles Best, Ling Zhong, et al.
British Journal of Haematology|July 1, 1995
The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionI Cunningham, S J MacCallum, M D Nicholls, et al.
Pageof 25